Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for May 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Acne Medication Isotretinoin Increases Risk of Eye Disorders
WEDNESDAY, May 30 (HealthDay News) -- The acne medicine isotretinoin may be linked to a nearly two-fold increased risk of ocular adverse effects in users, according to a study published online April 16 in the Archives of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Childhood Obesity Linked to Idiopathic Intracranial HTN
FRIDAY, May 25 (HealthDay News) -- Overweight and obese children are at higher risk of developing idiopathic intracranial hypertension (IIH), particularly non-Hispanic white adolescent girls, according to a study published online May 24 in The Journal of Pediatrics.
Full Text
Epidemiology of Rosacea Described in United Kingdom
FRIDAY, May 18 (HealthDay News) -- The incidence of rosacea in the United Kingdom is 1.65 per 1,000 person-years, with alcohol consumption linked to a modest increase in risk and current smoking linked to an decreased risk, according to a study published online May 5 in the British Journal of Dermatology.
Abstract
Full Text (subscription or payment may be required)
Retinal Vessel Diameter Linked to Heart Disease, Hypertension
THURSDAY, May 17 (HealthDay News) -- Baseline retinal vessel diameter is an independent predictor of incident hypertension, lower extremity arterial disease (LEAD), and any cardiovascular disease (CVD) at six years in African-American patients with type 1 diabetes mellitus, according to a study published in the May issue of the Archives of Ophthalmology.
Abstract
Full Text
Subretinal Prosthesis Shows Promise in Rats
TUESDAY, May 15 (HealthDay News) -- Micron-sized solar panel-like devices implanted underneath the retina of rats can generate electrical signals and may allow vision to be restored in individuals with degenerative eye diseases, according to a study published online May 13 in Nature Photonics.
Abstract
Full Text (subscription or payment may be required)
Screening for Retinopathy Every Two Years Deemed Safe
TUESDAY, May 15 (HealthDay News) -- For patients with type 2 diabetes without evidence of retinopathy, increasing the screening interval to every two years yields no increased risk of retinopathy-mediated vision loss and reduces screening costs, according to a study published online May 7 in Diabetes Care.
Abstract
Full Text (subscription or payment may be required)
Avastin and Lucentis Equally Improve Visual Acuity in AMD
WEDNESDAY, May 9 (HealthDay News) -- Avastin (bevacizumab) and Lucentis (ranibizumab) have similar effects on visual acuity in age-related macular degeneration (AMD), according to a study published online May 2 in Ophthalmology.
Abstract
Full Text (subscription or payment may be required)
Lack of Sleep Not Necessarily Detrimental to Surgical Skills
WEDNESDAY, May 9 (HealthDay News) -- Sleep-deprived medical students are able to perform and learn surgical skills, although they have an increased total subjective mental workload, according to a study published in the January issue of the American Journal of Surgery.
Abstract
Full Text (subscription or payment may be required)
Methodological Heterogeneity Seen in Clinical Trials
TUESDAY, May 1 (HealthDay News) -- Clinical studies registered with ClinicalTrials.gov from 2007 and 2010 are predominately small, single-center trials and contain significant heterogeneity in methodology, according to a study published in the May 2 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
|
